Apex BioTechnology Corp. · Class II · Cleared May 7, 2015
| K-number | K143750 |
| Device name | MEG-2B Blood Glucose Monitoring System, MEG-2B Pro Blood Glucose Monitoring System |
| Applicant | Apex BioTechnology Corp. |
| Product code | CGA |
| Device class | Class II |
| Decision date | May 7, 2015 |
| Decision | Substantially Equivalent |
| Regulation | 862.1345 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov